ACTIVITY OF CYTOSTATIC DRUGS IN 2 HETEROTRANSPLANTED HUMAN TESTICULAR CANCER CELL-LINES WITH DIFFERENT SENSITIVITY TO STANDARD AGENTS

被引:11
作者
HARSTRICK, A
SCHMOLL, HJ
CASPER, J
WILKE, H
POLIWODA, H
机构
[1] Department of Hematology and Oncology, University of Hannover Medical School, 3000 Hannover 61
关键词
D O I
10.1016/0277-5379(90)90195-Y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Two established human testicular cancer cell lines were used in a mouse xenograft model to assess the antitumour activity of 15 anticancer agents. Line H 12.1 was highly sensitive to cisplatin, bleomycin and vinblastine, resembling non-pretreated testicular tumours, whereas line H 23.1 showed resistance to cisplatin and vinblastine, comparable to tumours with acquired or intrinsic drug resistance. In line H 12.1 several drugs were highly active, including cyclophosphamide, ifosfamide, nimustine and vincristine; carmustine, vindesine, doxorubicin, epidoxorubicin, pirarubicin, mitoxantrone, carboplatin and iproplatin had only moderate activity. In line H 23.1 only cyclophosphamide, ifosfamide, nimustine, vincristine and bleomycin had antitumour activity. These two cell lines represent a useful model for preclinical evaluation of new agents with presumed activity in testis cancer. © 1990.
引用
收藏
页码:898 / 901
页数:4
相关论文
共 21 条
[1]   VAB-6 - AN EFFECTIVE CHEMOTHERAPY REGIMEN FOR PATIENTS WITH GERM-CELL TUMORS [J].
BOSL, GJ ;
GLUCKMAN, R ;
GELLER, NL ;
GOLBEY, RB ;
WHITMORE, WF ;
HERR, H ;
SOGANI, P ;
MORSE, M ;
MARTINI, N ;
BAINS, M ;
MCCORMACK, P .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) :1493-1499
[2]   ALTERNATING CYCLES OF ETOPOSIDE PLUS CISPLATIN AND VAB-6 IN THE TREATMENT OF POOR-RISK PATIENTS WITH GERM-CELL TUMORS [J].
BOSL, GJ ;
GELLER, NL ;
VOGELZANG, NJ ;
CAREY, R ;
AUMAN, J ;
WHITMORE, WF ;
HERR, H ;
MORSE, M ;
SOGANI, P ;
CHAN, E .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) :436-440
[3]  
BUCKNER CD, 1974, CANCER CHEMOTH REP 1, V58, P709
[4]  
Fiebig H H, 1984, Behring Inst Mitt, P343
[5]  
HASTRICK A, 1989, CANCER, V63, P1079
[6]   GROWTH-CHARACTERISTICS OF HUMAN COLORECTAL TUMORS DURING SERIAL PASSAGE IN IMMUNE-DEPRIVED MICE [J].
HOUGHTON, JA ;
TAYLOR, DM .
BRITISH JOURNAL OF CANCER, 1978, 37 (02) :213-223
[7]   CYCLIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN PLUS VINBLASTINE AND BLEOMYCIN IN ADVANCED GERMINAL TUMORS - RESULTS WITH 100 PATIENTS [J].
LOGOTHETIS, CJ ;
SAMUELS, ML ;
SELIG, DE ;
OGDEN, S ;
DEXEUS, F ;
SWANSON, D ;
JOHNSON, D ;
VONESCHENBACH, A .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (02) :219-228
[8]  
OZOLS RF, 1988, CLIN ONCOL, V6, P486
[9]  
ROTH BJ, 1988, SEMIN ONCOL, V15, P345
[10]   CIS-DIAMMINEDICHLOROPLATINUM(II) - NEW ANTICANCER DRUG [J].
ROZENCWEIG, M ;
VONHOFF, DD ;
SLAVIK, M ;
MUGGIA, FM .
ANNALS OF INTERNAL MEDICINE, 1977, 86 (06) :803-812